Innovation, resilience, and economic growth are hallmarks of the life sciences sector. In response, developers accelerated construction activity, with life sciences projects under construction accounting for 17 percent of the total U.S. life sciences inventory in the second quarter of 2023. According to Cushman & Wakefield’s latest Life Sciences Update report, supply is now outpacing demand in several key markets. Expand CloseMeanwhile, life sciences investment activity is showing early signs of renewed momentum. The life sciences sector is at a crossroads, balancing the excitement of technological breakthroughs with the realities of economic and regulatory challenges.